Author

Robert L. Fairchild

Cleveland ClinicORCID 0000-0002-7107-5259Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Organism:mouse· 3 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Karen S. KeslariD· 3 shared William M. BaldwiniD· 3 shared Danielle D. KishiD· 2 shared Nina DvorinaiD· 2 shared Anat R. TamburiD· 1 shared Brian D. SoutherniD· 1 shared Chengsong ZhuiD· 1 shared Daigo OkadaiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Karen S. KeslarORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

NK Cells Effectively Mediating Antibody-Mediated Kidney Allograft Rejection Requires a Specific Activation Receptor and Graft Expression of the Ligand

Yuki Maruyama, Daigo Okada, Hidetoshi Tsuda, Danielle D. Kish, Karen S. Keslar, Nina Dvorina, William M. Baldwin, Robert L. Fairchild

This study shows that NK cell activation via NKG2D and graft Rae-1e ligand is essential for antibody-mediated kidney allograft rejection, even with high DSA levels.

bioRxiv · Mar 5, 2026 · PreprintImmunology

NK cell allorecognition shapes reprogramming of neutrophils infiltrating heart allografts

Erik H. Koritzinsky, Karen S. Keslar, Robert L. Fairchild, Jayati Mookerjee Basu

This study shows that NK cell allorecognition reprograms neutrophils in heart allografts, leading to a novel hybrid neutrophil subset that may impact transplant outcomes.

bioRxiv · Sep 28, 2025 · PreprintImmunology

Inhibition of De Novo Autoantibody Production Attenuates Chronic Antibody-Mediated Rejection of Kidney Allografts Despite Maintenance of High Donor-Specific Antibody Titers

Yosuke Mitsui, Karen S. Keslar, Michael Nicosia, Danielle D. Kish, Nina Dvorina, Chengsong Zhu, Mitchell A. Olman, Brian D. Southern, William M. Baldwin, Robert L. Fairchild

The paper shows that inhibiting de novo autoantibody production reduces chronic antibody-mediated rejection of kidney allografts, even when donor-specific antibody titers remain high.

bioRxiv · Jun 11, 2025 · PreprintImmunology

Compartmentalization of Transcripts During Antibody Mediated Rejection in Renal Transplants

Dajana Margeta, Hirotsugu Noguchi, Sepideh Khazaie, Leal C. Herlitz, Joshua J. Augustine, Peter S. Heeger, Anat R. Tambur, Robert L. Fairchild, William M. Baldwin

The paper uses Digital Spatial Profiling to analyze transcript localization in renal transplant biopsies, showing compartmentalized immune responses and persistent podocyte transcript reduction during antibody-mediated rejection.

Clinical Immunology · May 22, 2024Peer-reviewedPathology